Ventrus drops piles drug, shares hit life-low
06:30 EDT 25 Jun 2012 | Reuters
(Reuters) - Ventrus Biosciences Inc's experimental drug to treat piles failed in a late-stage trial, and the company said it would stop developing the drug to reduce costs, sending its shares to a life low.
Original Article: Ventrus drops piles drug, shares hit life-low
More From BioPortfolio on "Ventrus drops piles drug, shares hit life-low"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
